PMV Pharmaceuticals (PMVP) Change in Acquisitions & Divestments (2019 - 2026)

PMV Pharmaceuticals (PMVP) has 8 years of Change in Acquisitions & Divestments data on file, last reported at $31.5 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 29.13% year-over-year to $31.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $145.4 million (down 23.15% YoY) and the FY2025 annual result came in at $158.4 million, down 21.61% from the prior year.
• Change in Acquisitions & Divestments slipped to $31.5 million in Q1 2026, from $39.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $76.9 million in Q3 2022 to a low of $24.0 million in Q3 2023.
• A 5-year average of $47.0 million and a median of $43.7 million in 2022 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2023 — Change in Acquisitions & Divestments sank 68.77% — and 2024, when it surged 135.37%.
• Tracing PMVP's Change in Acquisitions & Divestments over 5 years: stood at $59.5 million in 2022, then sank by 47.94% to $31.0 million in 2023, then surged by 45.45% to $45.1 million in 2024, then retreated by 12.4% to $39.5 million in 2025, then dropped by 20.25% to $31.5 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $31.5 million (Q1 2026), $39.5 million (Q4 2025), and $32.5 million (Q3 2025), per Business Quant data.